DCM

DAFNA Capital Management Portfolio holdings

AUM $431M
1-Year Est. Return 68.38%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+68.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$405M
AUM Growth
+$42.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$3.93M
2
+$2.46M
3
+$2.02M
4
INSP icon
Inspire Medical Systems
INSP
+$1.74M
5
AQST icon
Aquestive Therapeutics
AQST
+$1.6M

Top Sells

1
+$21.6M
2
+$11.6M
3
+$7.37M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$6.23M
5
URGN icon
UroGen Pharma
URGN
+$5.78M

Sector Composition

1 Healthcare 85.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STXS icon
1
Stereotaxis
STXS
$202M
$42.5M 10.51%
13,680,554
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$8.13B
$40.2M 9.94%
401,505
-14,000
RVMD icon
3
Revolution Medicines
RVMD
$19.7B
$30.7M 7.58%
657,176
-20,000
CYTK icon
4
Cytokinetics
CYTK
$7.61B
$21.7M 5.36%
394,940
-3,160
ATRC icon
5
AtriCure
ATRC
$1.56B
$20.9M 5.16%
592,273
MRUS
6
DELISTED
Merus
MRUS
$20.8M 5.13%
220,451
-178,353
IBB icon
7
iShares Biotechnology ETF
IBB
$8.58B
$14.8M 3.66%
102,500
IDYA icon
8
IDEAYA Biosciences
IDYA
$2.83B
$14.7M 3.63%
539,923
-79,167
AXGN icon
9
Axogen
AXGN
$1.59B
$13.2M 3.27%
742,282
+500
XENE icon
10
Xenon Pharmaceuticals
XENE
$3.34B
$11.6M 2.86%
287,939
NBIX icon
11
Neurocrine Biosciences
NBIX
$13.3B
$9.91M 2.45%
70,615
RCUS icon
12
Arcus Biosciences
RCUS
$2.52B
$8.54M 2.11%
627,626
SNDX icon
13
Syndax Pharmaceuticals
SNDX
$1.89B
$7.7M 1.9%
500,702
-42,900
DAWN icon
14
Day One Biopharmaceuticals
DAWN
$1.09B
$7.04M 1.74%
999,163
+120,000
ASND icon
15
Ascendis Pharma
ASND
$14.3B
$6.6M 1.63%
33,177
-39,500
KALV icon
16
KalVista Pharmaceuticals
KALV
$823M
$5.15M 1.27%
422,731
-159,026
BCAX
17
Bicara Therapeutics
BCAX
$919M
$5.01M 1.24%
317,001
INGN icon
18
Inogen
INGN
$166M
$4.95M 1.22%
605,625
CMPS
19
Compass Pathways
CMPS
$783M
$4.65M 1.15%
811,046
GLPG icon
20
Galapagos
GLPG
$2.22B
$4.51M 1.11%
130,175
DXCM icon
21
DexCom
DXCM
$28.3B
$4.41M 1.09%
65,552
TNDM icon
22
Tandem Diabetes Care
TNDM
$1.72B
$4.31M 1.07%
355,208
+61,000
KURA icon
23
Kura Oncology
KURA
$760M
$4.1M 1.01%
463,368
ALKS icon
24
Alkermes
ALKS
$4.97B
$4.04M 1%
134,748
+31,000
STOK icon
25
Stoke Therapeutics
STOK
$2.08B
$3.99M 0.99%
169,791
-332,181
1
2 3 4